Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants
Trial details
- Registry ID
- NCT00284986
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD ParticipantsNCT00284986 | Mesoblast, Inc. | Phase 2 | Completed | 2006-04-25Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |